These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15599929)

  • 81. Fas and FasL in the homeostatic regulation of immune responses.
    Lynch DH; Ramsdell F; Alderson MR
    Immunol Today; 1995 Dec; 16(12):569-74. PubMed ID: 8579749
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Involvement of Fas/FasL system in the pathogenesis of autoimmune diseases and Wilson's disease.
    Stassi G; Di Felice V; Todaro M; Cappello F; Zummo G; Farina F; Trucco M; De Maria R
    Arch Immunol Ther Exp (Warsz); 1999; 47(3):129-33. PubMed ID: 10470438
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The role of Fas ligand in immune privilege.
    Green DR; Ferguson TA
    Nat Rev Mol Cell Biol; 2001 Dec; 2(12):917-24. PubMed ID: 11733771
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
    Mollinedo F; Gajate C
    Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Activation-induced cell death in T cells and autoimmunity.
    Zhang J; Xu X; Liu Y
    Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Membrane protein Fas/FasL system in viral infections].
    Ma BJ; Hang CS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):94-7. PubMed ID: 12526314
    [No Abstract]   [Full Text] [Related]  

  • 87. Fas (CD95)-related apoptosis and rheumatoid arthritis.
    Peng SL
    Rheumatology (Oxford); 2006 Jan; 45(1):26-30. PubMed ID: 16159946
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease: potential for therapeutic inhibition.
    French LE; Tschopp J
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1656-61. PubMed ID: 11103436
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [The role of Fas/FasL in tuberculosis].
    Liu JH; Wang YN; Zhang CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):783-6. PubMed ID: 15634397
    [No Abstract]   [Full Text] [Related]  

  • 90. Fas ligand as a tool for immunosuppression and generation of immune tolerance.
    Bohana-Kashtan O; Civin CI
    Stem Cells; 2004; 22(6):908-24. PubMed ID: 15536183
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Contribution of Japanese researchers to progress in the study of allergy and collagen disease in the last 100 years: Fas and autoimmune diseases].
    Eguchi K
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91(9):2599-603. PubMed ID: 12373878
    [No Abstract]   [Full Text] [Related]  

  • 92. Gene therapy for tolerance and autoimmunity: soon to be fulfilled promises?
    El-Amine M; Melo ME; Scott DW
    Clin Immunol; 2001 Apr; 99(1):1-6. PubMed ID: 11286536
    [No Abstract]   [Full Text] [Related]  

  • 93. Role of Fas/FasL interaction in physiology and pathology: the good and the bad.
    Sakata K; Sakata A; Kong L; Dang H; Talal N
    Clin Immunol Immunopathol; 1998 Apr; 87(1):1-7. PubMed ID: 9576004
    [No Abstract]   [Full Text] [Related]  

  • 94. Immunology and immunopathology of male genital tract. Preface.
    Lenzi A
    Hum Reprod Update; 2001; 7(5):443. PubMed ID: 11556489
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.